GV

By Laura Lovett 03:11 pm June 9, 2020
This morning Boston-based startup PatientPing scored $60 million in Series C funding to propel the expansion of its care-coordination app. Andreessen Horowitz, F-Prime Capital, GV, and Transformation Capital led the round with participation from existing investors.  This news comes nearly four years after PatientPing closed its $31.6 million Series B round in 2016, which was also led by Andreesen...
By Laura Lovett 03:47 pm February 5, 2020
This morning Verana Health, a startup focused on curating and analyzing real-world clinical data, announced a $100 million funding round led by GV with participation from Bain Capital Ventures, Casdin Capital and Define Ventures.  The funding news coincides with the announcement that Verana purchased PYA Analytics’ technology assets and team. PYA Analytics specializes in large-scale data...
By Laura Lovett 01:41 pm December 17, 2019
This morning Kindbody, a tech-enabled women’s health startup, announced a $4.5 million investment from GV, bringing the company’s total funding amount to $32 million.  This comes half a year after the New York-based company announced its $15 million Series A round let by RRE Ventures and Perceptive Advisors.  WHAT THEY DO This female-led startup uses a hybrid approach to care. It combines face-to...
By Laura Lovett 03:28 pm October 24, 2019
Healthcare AI company Viz.ai announced that it landed a whopping $50 million in Series B funding this morning. This latest infusion of cash was led by Greenoaks, with participation from Threshold Ventures, CRV, GV and Kleiner Perkins.  The new funding comes a little over a year after the Israeli company raised $21 million from Kleiner Perkins and GV.  WHAT THEY DO  Viz.ai focuses on using AI to...
By Dave Muoio 03:25 pm June 17, 2019
Quartet Health, a startup focused on behavioral health and primary care, has brought in another $60 million in funding, bringing its total raise to $153 million. The Series D round was headlined by Centene Corporation, with support from returning backers F-Prime Capital Partners, GV, Oak HC/FT and Polaris Partners. WHAT THEY DO Quartet’s integrated platform links providers, payers and services...
By Dave Muoio 12:10 pm June 17, 2019
Collective Health, an employee benefits platform that uses predictive analytics to match employees with programs, has raised $205 million in a Series E funding round led by SoftBank. New backers PSP Investments, DFJ Growth and G Squared also participated alongside returning backers Founders Fund, GV, Maverick Ventures, Mubadala Ventures, NEA and Sun Life. WHAT THEY DO Since its launch in 2013,...
By Dave Muoio 12:03 pm May 21, 2019
Cala Health, a wearable neuromodulation therapy startup focused on chronic diseases, has closed a $50 million Series C financing round. Novartis, Baird Capital, LifeSci Venture Partners, TriVentures and other unnamed backers participated, as did returning investors JJDC, Lux Capital, Lightstone Ventures, Action Potential Venture Capital, dRx Capital and GV. WHAT THEY DO Stanford University...
By Jonah Comstock 01:50 pm January 22, 2019
The Pill Club, a company that provides telemedicine and mail-order pharmacy services to help women access birth control, has raised $51 million in Series B funding, bringing its total funding up to $67 million. VMG led the round with participation from GV and ACME Capital (new investors) as well as Base10 and Shasta Ventures (existing investors). What they do Through The Pill Club's online...
DigiSight rebrands as Verana Health, pivots into data science

Verana Health CEO and President Miki Kapoor

By Jonah Comstock 02:00 pm July 31, 2018
Tele-ophthalmology company DigiSight — now called Verana Health — has a new name, a new mission, a new CEO, and $30 million dollars in new funding led by Alphabet subsidiary GV (formerly Google Ventures). Additional contributors to the round include Biomatics Capital, Brook Byers (founder of Kleiner, Perkins, Caufield & Byers), GE Ventures, and Lagunita Biosciences, all existing investors. "...
By Dave Muoio 02:50 pm July 18, 2018
Healthcare AI company Viz.ai announced today that it has raised $21 million in Series A funding. The investment was led by Kleiner Perkins, with additional participation from GV (formerly Google Ventures). Viz.ai’s primary product is Contact, the first FDA-cleared clinical decision support (CDS) tool that analyzes CT results and highlights cases that may have experienced a stroke for review by a...